NCT03369106Active, not recruiting
Mechanisms of Disease Severity in Multiple Sclerosis: an Integrative Multimodal Study
Source: ClinicalTrials.gov · Last updated 22 Oct 2026
Brief summary (registry, in English)
This study will identify a combination of disease severity markers (genetic, immunology, epigenetic, imaging) associated with disease severity and progression in a cohort of patients with multiple sclerosis.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 120 (estimated)
- First submitted
- 28 Nov 2017
- Start date
- 6 Feb 2018
- Primary completion date
- 15 Dec 2020
- Lead sponsor
- Institut National de la Santé Et de la Recherche Médicale, France
- Diseases
- Multiple sclerosis
- NCT number
- NCT03369106
What you commit to
- Study type: Observational
- Planned participants: 120
- From 6 Feb 2018 to the primary completion date, 15 Dec 2020
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Cyclophosphamide, mitoxantrone or methylprednisolone infusion within one month before inclusion
- Multiple sclerosis relapse within one month before inclusion
- Concomitant severe or uncontrolled disease
Who the study is looking for
- Clinically isolated syndrome or Multiple sclerosis (2010 Mc Donald criteria)
- Sibling having Clinically isolated syndrome or Multiple sclerosis (2010 Mc Donald criteria) willing to participate to the study
- Affiliated to the French social security or equivalent
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| CIC Neurosciences Institut du Cerveau et de la Moelle Epinière Coordinator of this site? Confirm its status | Paris | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.